These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluating a new protocol from the investigator's perspective. Wilder BJ; Hargrove SC Epilepsy Res Suppl; 1993; 10():181-4. PubMed ID: 8251094 [No Abstract] [Full Text] [Related]
3. Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods. Browne TR Epilepsy Res Suppl; 1993; 10():31-44. PubMed ID: 8251105 [No Abstract] [Full Text] [Related]
4. Role of the Institutional Review Board in clinical trials. Skolnick BE Epilepsy Res Suppl; 1993; 10():193-200. PubMed ID: 8251097 [No Abstract] [Full Text] [Related]
5. Patient recruitment and compliance issues in clinical trials. Cramer JA Epilepsy Res Suppl; 1993; 10():211-22. PubMed ID: 8251099 [No Abstract] [Full Text] [Related]
6. Sources of variability in clinical trials of new drugs for epilepsy. Leppik IE Epilepsy Res Suppl; 1993; 10():157-66. PubMed ID: 8251091 [No Abstract] [Full Text] [Related]
7. Study population selection. Treiman DM Epilepsy Res Suppl; 1993; 10():125-35. PubMed ID: 8251088 [No Abstract] [Full Text] [Related]
8. The role of the pharmacist in investigational AED trials. Graves NM Epilepsy Res Suppl; 1993; 10():201-9. PubMed ID: 8251098 [No Abstract] [Full Text] [Related]
9. Fostering the relationship between the clinical research associate and the drug study coordinator. Brodie MA Epilepsy Res Suppl; 1993; 10():233-7. PubMed ID: 8251101 [No Abstract] [Full Text] [Related]
10. Protocol design. Wilensky AJ Epilepsy Res Suppl; 1993; 10():107-13. PubMed ID: 8251086 [No Abstract] [Full Text] [Related]
11. Obstacles encountered in designing antiepileptic drug trials. French JA Epilepsy Res Suppl; 1993; 10():81-9. PubMed ID: 8251107 [No Abstract] [Full Text] [Related]
12. External influences on protocol design. Spilker B Epilepsy Res Suppl; 1993; 10():115-24. PubMed ID: 8251087 [No Abstract] [Full Text] [Related]
13. European investigational antiepilepsy drug trials. Sussman NM Epilepsy Res Suppl; 1993; 10():149-55. PubMed ID: 8251090 [No Abstract] [Full Text] [Related]
14. New drug treatments in epilepsy. Kuntzer T Eur Neurol; 1994; 34(1):4-10. PubMed ID: 8137837 [No Abstract] [Full Text] [Related]
15. Preparing for an FDA audit. Barnes D Epilepsy Res Suppl; 1993; 10():245-50. PubMed ID: 8251103 [No Abstract] [Full Text] [Related]
16. The impact of foreign data on a new drug application. Galbraith H; Walker SD Adv Neurol; 1998; 76():143-7. PubMed ID: 9408471 [No Abstract] [Full Text] [Related]
17. Evaluation of clinical efficacy in antiepileptic drug trials. Schmidt D Epilepsy Res Suppl; 1991; 3():69-77. PubMed ID: 1777084 [No Abstract] [Full Text] [Related]
18. Review of the newer antiepileptic drugs. Tidwell A; Swims M Am J Manag Care; 2003 Mar; 9(3):253-76; quiz 277-9. PubMed ID: 12643343 [TBL] [Abstract][Full Text] [Related]
19. [Documentation of findings in the clinical testing of antiepileptics with optical marking-reader device]. Doose H; Helmchen H; Ketz E; Künkel H; Matthes A; Oberhoffer G; Penin H; Rabe F; Scheffner D Arzneimittelforschung; 1967 Jan; 17(1):85-93. PubMed ID: 4879880 [No Abstract] [Full Text] [Related]
20. The domestic drug regulatory process: why time is of the essence. Katz R Epilepsy Res Suppl; 1993; 10():91-106. PubMed ID: 8251109 [No Abstract] [Full Text] [Related] [Next] [New Search]